RTI Surgical (NASDAQ:RTIX) Receives Daily Coverage Optimism Rating of 0.11

Headlines about RTI Surgical (NASDAQ:RTIX) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RTI Surgical earned a news impact score of 0.11 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 46.5521225809052 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Shares of RTIX stock traded up $0.15 during midday trading on Wednesday, hitting $4.90. The stock had a trading volume of 58,956 shares, compared to its average volume of 149,179. The stock has a market capitalization of $301.24, a PE ratio of 80.00, a PEG ratio of 2.67 and a beta of 1.69. RTI Surgical has a one year low of $3.58 and a one year high of $6.00. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.39 and a current ratio of 3.50.

RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings results on Thursday, March 1st. The medical equipment provider reported $0.03 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.04 by ($0.01). The company had revenue of $70.82 million during the quarter, compared to analysts’ expectations of $70.16 million. RTI Surgical had a net margin of 2.24% and a return on equity of 2.88%. analysts predict that RTI Surgical will post 0.12 EPS for the current fiscal year.

RTIX has been the topic of several research reports. BidaskClub lowered RTI Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, December 5th. Craig Hallum upgraded RTI Surgical from a “hold” rating to a “buy” rating in a research note on Friday, March 2nd. Finally, Zacks Investment Research lowered RTI Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, March 6th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the stock. The company has an average rating of “Hold”.

ILLEGAL ACTIVITY NOTICE: This story was originally published by BBNS and is the sole property of of BBNS. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://baseballnewssource.com/2018/03/21/rti-surgical-rtix-given-news-sentiment-rating-of-0-11/1923766.html.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

 




Latest News

Ji-Man Choi Receives Another Chance in Milwaukee
Ji-Man Choi Receives Another Chance in Milwaukee
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Strikeouts Once Again Plaguing Cubs
Strikeouts Once Again Plaguing Cubs
Atlanta Braves: A Mix of Young and Old
Atlanta Braves: A Mix of Young and Old
Major League Baseball is Back and Astros Favored to Repeat
Major League Baseball is Back and Astros Favored to Repeat
Jim Kaat: Baseball Would Be Helped by Shortening Game to Seven Innings
Jim Kaat: Baseball Would Be Helped by Shortening Game to Seven Innings


Leave a Reply

 
© 2006-2018 BBNS.